Back to Search Start Over

The genetic landscape of neuro-related proteins in human plasma.

Authors :
Repetto L
Chen J
Yang Z
Zhai R
Timmers PRHJ
Feng X
Li T
Yao Y
Maslov D
Timoshchuk A
Tu F
Twait EL
May-Wilson S
Muckian MD
Prins BP
Png G
Kooperberg C
Johansson Å
Hillary RF
Wheeler E
Pan L
He Y
Klasson S
Ahmad S
Peters JE
Gilly A
Karaleftheri M
Tsafantakis E
Haessler J
Gyllensten U
Harris SE
Wareham NJ
Göteson A
Lagging C
Ikram MA
van Duijn CM
Jern C
Landén M
Langenberg C
Deary IJ
Marioni RE
Enroth S
Reiner AP
Dedoussis G
Zeggini E
Sharapov S
Aulchenko YS
Butterworth AS
Mälarstig A
Wilson JF
Navarro P
Shen X
Source :
Nature human behaviour [Nat Hum Behav] 2024 Nov; Vol. 8 (11), pp. 2222-2234. Date of Electronic Publication: 2024 Aug 29.
Publication Year :
2024

Abstract

Understanding the genetic basis of neuro-related proteins is essential for dissecting the molecular basis of human behavioural traits and the disease aetiology of neuropsychiatric disorders. Here the SCALLOP Consortium conducted a genome-wide association meta-analysis of over 12,000 individuals for 184 neuro-related proteins in human plasma. The analysis identified 125 cis-regulatory protein quantitative trait loci (cis-pQTL) and 164 trans-pQTL. The mapped pQTL capture on average 50% of each protein's heritability. At the cis-pQTL, multiple proteins shared a genetic basis with human behavioural traits such as alcohol and food intake, smoking and educational attainment, as well as neurological conditions and psychiatric disorders such as pain, neuroticism and schizophrenia. Integrating with established drug information, the causal inference analysis validated 52 out of 66 matched combinations of protein targets and diseases or side effects with available drugs while suggesting hundreds of repurposing and new therapeutic targets.<br />Competing Interests: Competing interests P.R.H.J.T. is a salaried employee of BioAge Labs, Inc. R.E.M. has received a speaker fee from Illumina, is an advisor to the Epigenetic Clock Development Foundation and is a scientific consultant for Optima Partners. E.W. is now an employee of AstraZeneca. Y.S.A. is now an employee of GSK. A.S.B. has received grants from AstraZeneca, Bayer, Biogen, BioMarin and Sanofi. A.M. is an employee of Pfizer. X.S. is the founder of Quantix BioSciences and has received a speaker fee from Olink Proteomics. The remaining authors declare no competing interests.<br /> (© 2024. The Author(s), under exclusive licence to Springer Nature Limited.)

Details

Language :
English
ISSN :
2397-3374
Volume :
8
Issue :
11
Database :
MEDLINE
Journal :
Nature human behaviour
Publication Type :
Academic Journal
Accession number :
39210026
Full Text :
https://doi.org/10.1038/s41562-024-01963-z